Member Info for Formul1187

rns tomorrow ? looking well primed for the next lift

1.2p tomorrow 100% news still to sink in

1p finish ?

Sar heading for 1p

great day again think ill put some in to sar looking good with the rns today

emails a game changer

must say that research has to be the cracker great find newbie

harley st prices dont come cheap look at the wider picture of clients, nhs government pricing is discounted

cracking research nice one pal could be rns sooner then later

also has avact characteristics watch this fly

trolls you costing pi's money again trying to get in cheap you should be ashamed

mm's have let this go

l2's queing up up she goes

chuddun dont get ahead your self pal

hidden buys you cant see, i bet top dollar huge buys at 55,40p this will gap up tomorrow 100%

i dont get some people now you have to buy higher the news here is snowballing

people lost out on stop loses lol

mologic firing up for antigen testing

like your heading news, you really waiting an hour to buy lol

Key cytokines that are found elevated in Covid-19 patients that have been admitted to intensive care include IL-2, IL-7, IL-10 and G-CSF*, all of which signal via JAK-family kinases. As the Company noted in its half yearly report, a paper in the European Respiratory Journal published in 2017** suggested that TYK2 inhibition might be effective in the treatment of influenza driven secondary bacterial pneumonia, which is potentially highly relevant against the backdrop of the Covid-19 pandemic. The Company also notes that it is preparing grant applications to fund studies to assess the potential use of its TYK2/JAK1 inhibitors to address this threat to global public health.